1. Home
  2. APMD vs STK Comparison

APMD vs STK Comparison

Compare APMD & STK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Apnimed Inc. Common Stock

APMD

Apnimed Inc. Common Stock

N/A

Current Price

$16.65

Market Cap

895.5M

Sector

Health Care

ML Signal

N/A

Logo Columbia Seligman Premium Technology Growth Fund Inc

STK

Columbia Seligman Premium Technology Growth Fund Inc

N/A

Current Price

$49.94

Market Cap

921.0M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
APMD
STK
Founded
2017
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
895.5M
921.0M
IPO Year
2026
2009

Fundamental Metrics

Financial Performance
Metric
APMD
STK
Price
$16.65
$49.94
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
★ $50.33
N/A
AVG Volume (30 Days)
★ 346.0K
42.6K
Earning Date
11-24-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$136.18
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.88
$32.50
52 Week High
$35.29
$58.46

Technical Indicators

Market Signals
Indicator
APMD
STK
Relative Strength Index (RSI) 44.15 43.81
Support Level $16.43 $47.02
Resistance Level $19.83 $53.92
Average True Range (ATR) 1.52 1.63
MACD 0.28 -0.14
Stochastic Oscillator 46.55 31.96

Price Performance

Historical Comparison
APMD
STK

About APMD Apnimed Inc. Common Stock

Apnimed Inc is a late clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of novel oral therapies that address the neurobiology of sleep related breathing diseases. The company's flagship product candidate, AD109, or Oxnimbi, is an investigational, fixed-dose oral combination of a novel anti-muscarinic and selective norepinephrine reuptake inhibitor for the treatment of obstructive sleep apnea (OSA).

About STK Columbia Seligman Premium Technology Growth Fund Inc

Columbia Seligman Premium Technology Growth Fund Inc is a closed-end management investment company. Its investment objective is to seek growth of capital and current income. The fund invests in various sectors such as consumer discretionary, industrials, information technology and telecommunication services.

Share on Social Networks: